| Original language | English |
|---|---|
| Pages (from-to) | 1449-1456 |
| Journal | Journal of Thoracic Oncology |
| Volume | 7 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2012 |
Cite this
}
A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma. / Nowak, Anna; Millward, Michael; Creaney, Jenette; Francis, Roslyn; Dick, Ian; Hasani, Arman; Van Der Schaaf, A.; Segal, A.; Musk, Arthur; Byrne, Michael.
In: Journal of Thoracic Oncology, Vol. 7, No. 9, 2012, p. 1449-1456.Research output: Contribution to journal › Article
TY - JOUR
T1 - A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma
AU - Nowak, Anna
AU - Millward, Michael
AU - Creaney, Jenette
AU - Francis, Roslyn
AU - Dick, Ian
AU - Hasani, Arman
AU - Van Der Schaaf, A.
AU - Segal, A.
AU - Musk, Arthur
AU - Byrne, Michael
PY - 2012
Y1 - 2012
U2 - 10.1097/JTO.0b013e31825f22ee
DO - 10.1097/JTO.0b013e31825f22ee
M3 - Article
VL - 7
SP - 1449
EP - 1456
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
SN - 1556-0864
IS - 9
ER -